Cargando…

Antihyperglycemic Medications and Cardiovascular Risk Reduction

Cardiovascular disease (CVD) remains a leading cause of death in patients with type 2 diabetes (T2D). In addition to glycemic control, a major focus of diabetes treatment involves cardiovascular (CV) risk reduction. In 2008, the US Food and Drug Administration (FDA) instituted a new requirement that...

Descripción completa

Detalles Bibliográficos
Autores principales:	Anderson, Sarah L, Marrs, Joel C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Touch Medical Media 2017
Materias:	Cardiovascular Risk Reduction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5813471/ https://www.ncbi.nlm.nih.gov/pubmed/29632614 http://dx.doi.org/10.17925/EE.2017.13.02.86

Ejemplares similares

Comparative Effectiveness of the Sodium–Glucose Cotransporter 2 Inhibitor Empagliflozin Versus Other Antihyperglycemics on Risk of Major Adverse Kidney Events
por: Xie, Yan, et al.
Publicado: (2020)

Cardiovascular Risk Reduction With Liraglutide: An Exploratory Mediation Analysis of the LEADER Trial
por: Buse, John B., et al.
Publicado: (2020)

Physical Activity and Factors Affecting Its Maintenance Among Patients With Coronary Heart Disease Not Undergoing Cardiac Rehabilitation in China
por: Wang, Jianhui, et al.
Publicado: (2020)

A clinical-genetic approach to assessing cardiovascular risk in patients with CKD
por: Rodrigo, Emilio, et al.
Publicado: (2017)

Association between normal or mildly reduced kidney function, cardiovascular risk and biomarkers for atherosclerosis: results from the ENCORE trial
por: Tyson, Crystal C., et al.
Publicado: (2017)

Association between office visit intervals and long‐term cardiovascular risk in hypertensive patients
por: Kim, Duon, et al.
Publicado: (2023)

Relationship between flow-mediated vasodilation and cardiovascular risk factors in a large community-based study
por: Maruhashi, Tatsuya, et al.
Publicado: (2013)

A cardiovascular risk prediction model for older people: Development and validation in a primary care population
por: van Bussel, Emma F., et al.
Publicado: (2019)

Change in Dynamic Hyperinflation After Bronchoscopic Lung Volume Reduction in Patients with Emphysema
por: van Dijk, Marlies, et al.
Publicado: (2020)

Regression From Prediabetes to Normal Glucose Regulation Is Associated With Reduction in Cardiovascular Risk: Results From the Diabetes Prevention Program Outcomes Study
por: Perreault, Leigh, et al.
Publicado: (2014)

Early Menopause and Cardiovascular Disease Risk in Women With or Without Type 2 Diabetes: A Pooled Analysis of 9,374 Postmenopausal Women
por: Yoshida, Yilin, et al.
Publicado: (2021)

Risk of cardiovascular event and mortality in relation to refill and guideline adherence to lipid-lowering medications among patients with type 2 diabetes mellitus in Sweden
por: Karlsson, Sofia Axia, et al.
Publicado: (2019)

Increased Risk of Cardiovascular Disease in Young Women Following Gestational Diabetes Mellitus
por: Shah, Baiju R., et al.
Publicado: (2008)

Genetic Risk Score Associations With Cardiovascular Disease and Mortality in the Diabetes Heart Study
por: Cox, Amanda J., et al.
Publicado: (2014)

Prevalence of diabetes and cardiovascular risk factors in middle-class urban participants in India
por: Gupta, Arvind, et al.
Publicado: (2014)

Outcomes of Combined Cardiovascular Risk Factor Management Strategies in Type 2 Diabetes: The ACCORD Randomized Trial
por: Margolis, Karen L., et al.
Publicado: (2014)

Cardiac autonomic neuropathy and risk of cardiovascular disease and mortality in type 1 and type 2 diabetes: a meta-analysis
por: Chowdhury, Mahin, et al.
Publicado: (2021)

Habitual intake of anthocyanins and flavanones and risk of cardiovascular disease in men(1)(2)
por: Cassidy, Aedín, et al.
Publicado: (2016)

High-throughput multivariable Mendelian randomization analysis prioritizes apolipoprotein B as key lipid risk factor for coronary artery disease
por: Zuber, Verena, et al.
Publicado: (2020)

Risk Prediction of Cardiovascular Disease in Type 2 Diabetes: A risk equation from the Swedish National Diabetes Register
por: Cederholm, Jan, et al.
Publicado: (2008)

Cardiovascular risk management in people with type 1 diabetes: performance using three guidelines
por: Varkevisser, Rita Delphine Maiko, et al.
Publicado: (2022)

Electrocardiographic Abnormalities and Cardiovascular Disease Risk in Type 1 Diabetes: The Epidemiology of Diabetes Interventions and Complications (EDIC) Study
por: Soliman, Elsayed Z., et al.
Publicado: (2017)

Cardiovascular Risk Factors Among Youth With and Without Type 2 Diabetes: Differences and possible mechanisms
por: West, Nancy A., et al.
Publicado: (2009)

Orange juice–derived flavanone and phenolic metabolites do not acutely affect cardiovascular risk biomarkers: a randomized, placebo-controlled, crossover trial in men at moderate risk of cardiovascular disease(1)(2)(3)(4)(5)
por: Schär, Manuel Y, et al.
Publicado: (2015)

Type 2 diabetes and the risk of cardiovascular events in peripheral artery disease versus coronary artery disease
por: Sprenger, Lukas, et al.
Publicado: (2021)

Lipid-lowering treatment patterns among patients with type 2 diabetes mellitus with high cardiovascular disease risk
por: Quek, Ruben G W, et al.
Publicado: (2015)

Effects of krill oil on endothelial function and other cardiovascular risk factors in participants with type 2 diabetes, a randomized controlled trial
por: Lobraico, Jessika M, et al.
Publicado: (2015)

ASCVD risk stratification modifies the effect of HbA1c on cardiovascular events among patients with type 2 diabetes mellitus with basic to moderate risk
por: Zhang, Hongmei, et al.
Publicado: (2020)

Incremental value of risk factor variability for cardiovascular risk prediction in individuals with type 2 diabetes: results from UK primary care electronic health records
por: Xu, Zhe, et al.
Publicado: (2022)

Higher burden of cardiometabolic and socioeconomic risk factors in women with type 2 diabetes: an analysis of the Glycemic Reduction Approaches in Diabetes (GRADE) baseline cohort
por: Gulanski, Barbara I, et al.
Publicado: (2023)

Trigger finger is associated with risk of incident cardiovascular disease in individuals with type 2 diabetes: a retrospective cohort study
por: Mineoka, Yusuke, et al.
Publicado: (2021)

Prevalence, incidence and predictors of cardiovascular risk factors: longitudinal data from rural and urban South India and comparison with global data
por: Vasan, Senthil K, et al.
Publicado: (2020)

Impaired fasting glucose, type 2 diabetes mellitus, and lifetime risk of cardiovascular disease among women and men: the Rotterdam Study
por: Ahmadizar, Fariba, et al.
Publicado: (2021)

PERS&O (PERsistent Sitagliptin treatment & Outcomes): observational retrospective study on cardiovascular risk evolution in patients with type 2 diabetes on persistent sitagliptin treatment
por: Buonaiuto, Giulia, et al.
Publicado: (2016)

Characteristics Associated With Decreased or Increased Mortality Risk From Glycemic Therapy Among Patients With Type 2 Diabetes and High Cardiovascular Risk: Machine Learning Analysis of the ACCORD Trial
por: Basu, Sanjay, et al.
Publicado: (2018)

Association Between Insulin Resistance and Cardiovascular Disease Risk Varies According to Glucose Tolerance Status: A Nationwide Prospective Cohort Study
por: Wang, Tiange, et al.
Publicado: (2022)

Diabetes with poor-control HbA1c is cardiovascular disease ‘risk equivalent’ for mortality: UK Biobank and Hong Kong population-based cohort study
por: Wan, Eric Yuk Fai, et al.
Publicado: (2023)

Influence of age on the prevalence and components of the metabolic syndrome and the association with cardiovascular disease
por: Devers, Marion C, et al.
Publicado: (2016)

High prevalence of cardiovascular risk factors and insulin resistance 6 years after hyperglycemia first detected in pregnancy in Cape Town, South Africa
por: Chivese, Tawanda, et al.
Publicado: (2019)

Hispanic representation in diabetes cardiovascular outcomes trials
por: Kelley, A. Taylor, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ub9f8rnbm5fimi05crp7kinuk1